B Braun Company Profile
✉ Email this page to a colleague
▶ Start for $100
Remove trial restrictions
What is the competitive landscape for B BRAUN, and what generic alternatives to B BRAUN drugs are available?
B BRAUN has one hundred and fifteen approved drugs.
There are two US patents protecting B BRAUN drugs.
There are twenty-seven patent family members on B BRAUN drugs in twenty-seven countries and two hundred and twenty-six supplementary protection certificates in sixteen countries.
Summary for B Braun
| International Patents: | 27 |
| US Patents: | 2 |
| Tradenames: | 223 |
| Ingredients: | 61 |
| NDAs: | 115 |
Drugs and US Patents for B Braun
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun | STERILE WATER FOR INJECTION IN PLASTIC CONTAINER | sterile water for injection | LIQUID;N/A | 019633-001 | Feb 29, 1988 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| B Braun | CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER | cefotaxime sodium | INJECTABLE;INJECTION | 050792-002 | Jul 29, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| B Braun | DEXTROSE 10% IN PLASTIC CONTAINER | dextrose | INJECTABLE;INJECTION | 018046-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for B Braun
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| B Braun | HEPATAMINE 8% | amino acids | INJECTABLE;INJECTION | 018676-001 | Aug 3, 1982 | 3,950,529 | ⤷ Sign Up |
| B Braun | UCEPHAN | sodium benzoate; sodium phenylacetate | SOLUTION;ORAL | 019530-001 | Dec 23, 1987 | 4,284,647 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for B Braun Drugs
Supplementary Protection Certificates for B Braun Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0252504 | SPC/GB96/060 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: IBANDRONIC ACID ((1-HYDROXY-3-(METHYLPENTYLAMINO) - PROPYLIDINE)-DIPHOSPHONIC ACID); REGISTERED: UK EU/1/96/012/001 19960625 |
| 1532149 | 92128 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: 8-(3-AMINOPIPERIDIN-1-YL)-7-BUT-2-INYL-3-METHYL-1-(4-METHYLCHINAZOLIN-2-YLMETHYL)-3, 7-DIHYDROPURIN-2, 6-DION, LES ENANTIOMERES ET LEURS SELS, EN PARTICULIER LA LINAGLIPTINE COMBINEE AVEC DU CHLORHYDRATE DE METFORMINE. LINAGLIPTINE |
| 2673237 | LUC00111 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; AUTHORISATION NUMBER AND DATE: EU/1/17/1173 20180326 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
